JAK2 Gene Mutation: Clinical Trials

3 trials for JAK2 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 active not recruiting. 2 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 12Terminated 2
Phase 21Active not recruiting 1

Follow JAK2 Gene Mutation: new trials by email Literature Review of JAK2 Gene Mutation trials Research Report on JAK2 Gene Mutation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Allogeneic Hematopoietic Stem Cell Transplantation, Irradiated Allogeneic Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia in Remission
Early Phase 1TerminatedRutgers, The State University of New Jersey22020-10-262023-06-26
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
Ruxolitinib - BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells
Phase 2Active not recruitingStanford University82019-11-152026-09-01
CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia
Continuous Positive Airway Pressure, Patient Observation, Questionnaire Administration - CALR Gene Mutation, Essential Thrombocythemia
Early Phase 1TerminatedUniversity of Utah82019-05-152024-01-08

Narrower conditions

Chromosome 17 deletion (1)  ·  Eosinophilia (1)  ·  Hematologic Neoplasms (1)  ·  Hepatomegaly (1)  ·  Hypereosinophilic Syndrome (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm, Residual (1)  ·  Polycythemia Vera (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Sleep Apnea, Obstructive (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Bone Marrow Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Apnea (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Platelet Disorders (1)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Neoplasms (1)  ·  Cardiovascular Diseases (1)  ·  Digestive System Diseases (1)  ·  Dyssomnias (1)

Interventions

Continuous Positive Airway Pressure (1)  ·  Observation (1)  ·  Watchful Waiting (1)  ·  ruxolitinib (1)

Sponsors

Rutgers, The State University of New Jersey (1)  ·  Stanford University (1)  ·  University of Utah (1)

Countries

United States (3)

Top investigators

Krishna Sundar (1)  ·  Roger Strair (1)  ·  William E Shomali, MD (1)

NIH funding

P30CA042014 (1), P30CA072720 (1)